Literature DB >> 7787614

Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment.

A Bush, M E Hodson, D M Geddes, M Rosenthal, R Dinwiddie, C Wallis, D E Stableforth, S P Conway, J M Littlewood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7787614      PMCID： PMC2549899          DOI： 10.1136/bmj.310.6993.1533a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Dornase alfa for cystic fibrosis.

Authors: 
Journal:  Drug Ther Bull       Date:  1995-02

Review 2.  Consensus conference: practical applications of Pulmozyme. September 22, 1993.

Authors:  B W Ramsey; H L Dorkin
Journal:  Pediatr Pulmonol       Date:  1994-06
  2 in total
  2 in total

1.  Dornase alfa for cystic fibrosis.

Authors:  G Robert; A Stevens; D Colin-Jones
Journal:  BMJ       Date:  1995-09-23

2.  Ivacaftor Therapy in CF Patients: Single Center Experience.

Authors:  Pritish Mondal; Amber Loyson; Jorge Lascano; Satyanarayan Hegde
Journal:  Adv Med       Date:  2014-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.